Evaluation of efficacy and safety of propofol in the treatment of procedural sedation/anesthesia in neonates: A protocol for systematic review and meta-Analysis

Abstract

Background: In newborns, propofol anesthesia is commonly utilized. Propofol is increasingly being shown to be effective and safe in treating procedural sedation and anesthesia in neonates. This research aims to evaluate the efficacy and safety of propofol in neonates using systematic review and meta-Analysis methodologies. Methods: A thorough review and meta-Analysis of studies on propofol anesthesia in neonates will be conducted. Conduct comprehensive searches in Web of Science, PubMed, Cochrane Library, EMBASE database, WanFang database, and Chinese biomedical literature database before May 25, 2021, to obtain published and qualified research. Two reviewers will assess the quality of the included papers and extract the data independently. Then, for meta-Analysis, we will utilize RevMan 5.3 software. Results: This study will pool the data of separate trials to analyze the efficacy and safety of propofol in the treatment of procedural sedation/anesthesia in neonates. Conclusion: Our findings will give strong data for determining whether propofol is an effective treatment for procedural anesthesia in neonates. Abbreviations: CBM = Chinese biomedical literature database, CI = Confidence intervals, MD = Mean difference, NICU = Neonatal intensive care units, NNTB = Number needed to treat for an additional beneficial outcome, NNTH = Number needed to treat for an additional harmful outcome, RT = Recovery times.